Skip to content
‹ Back to IndustriesHealthcare

Barrow Hanley Credit Partners: Lens on Credit Series | Credit Markets: Then vs. Now

Credit Markets: Then vs. Now Fixed Income Portfolio Managers Chet Paipanandiker and Nick Losey provide their views on expected rates hikes by 2023 and how they will impact the financial health of high yield companies. More about Chet Paipanandiker, Portfolio Manager More about Nick Losey, Portfolio Manager

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Credit Markets: Then vs. Now

Fixed Income Portfolio Managers Chet Paipanandiker and Nick Losey provide their views on expected rates hikes by 2023 and how they will impact the financial health of high yield companies.

More about Chet Paipanandiker, Portfolio Manager

More about Nick Losey, Portfolio Manager

Video TranscriptExpand ↓

Yes the credit markets have been in a pretty interesting place over the last three years. We've basically been through a mini credit cycle. If you think back to what happened, go back to the early part of 2020, basically at a global pandemic. And by virtue of the Fed stepping in and helping to solve capital markets as well as work to develop a vaccine, we actually saw a credit markets do a complete about face. We started out with companies contemplating zero revenues and by the latter part of the year with the benefit of a vaccine, as well as with the benefit of companies terming out maturities and raising cash, basically enhancing their liquidity. You saw revenues come back and you saw companies with pretty pumped up liquidity facilities. So as a result, they were able to better handle the stresses that were occurring at the time, whether it's because of revenues, labor availability or inflation. At the same time, something else was happening to the consumer. You basically saw the consumer also see its balance sheet get pumped up by virtue of the stimulus checks that came through. And so pretty much you went through this period of extreme volatility where companies and consumers were in a bad place. They basically didn't about ship and everyone ended up in a generally better place from a fundamental perspective. And so what did that do with credit markets? We certainly saw a swoon to the downside when COVID occurred. Credit markets rebounded. As you went to the earlier part of this year, we ended into a period of new stress, basically Russia invading Ukraine. And it's interesting to see what happened to credit spreads during that time frame. So on a year to date basis, what you basically saw was double B's were underperforming because the Fed was raising rates. At the same time, credit risk was actually outperforming single B's and triple C's on a relative basis to double B's. But come April of 2022, they actually started to reverse, and you saw double B's start to outperform. And there was an indication that credit stress might actually be more of a concern on people's minds. And so you actually saw single B's and triple C's begin to underperform on a relative basis to double B's. What we are seeing in the credit markets today is, you know, something that we hadn't seen in a number of decades in the past. You know, when we think about what's going on in the environment right now, we came into the beginning of the year where inflation started to increase. And then with Russia, Russia invading Ukraine, basically that kind of added a spark to kind of really set the fire on inflation. And now we're sitting it roughly at 9% year over year inflation rate. We haven't really seen this type of inflation environment for upwards of four decades. So when you think about the investing world, there are not that many participants in the markets today that have actually directly experienced what we are experiencing now or are likely to experience if inflation stays at very high levels for the foreseeable future. Now, when we think about inflation, basically we were concerned about the inflationary environment going into the beginning of this year. So we really pulled back on our exposure to duration, longer duration assets and have benefited, because of that. Now we do not believe that we are going to run rate at a 9% inflation rate. You're already starting to see a lot of your data points tick over, but do not believe that we're going back to this one to 2% inflation rate environment.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Why MVP wants to push fresher care-gap data into EMRs

Why MVP wants to push fresher care-gap data into EMRs

MVP Health Care, a nonprofit insurer in New York and Vermont, built Arcadia-based provider dashboards that combine ADT alerts, care gaps, utilization and pharmacy data. Timing drives the design. Its next step, delivering care gaps inside provider EMRs, should move fastest with practices that already exchange data through Arcadia.

  • 01For a quality measure on a seven-day clock, a payer report that runs a few months behind arrives after the deadline it was meant to help with.
  • 02The quickest EMR integrations for a regional payer are likely with practices already sharing data on the same platform through Medicare ACOs or other payers. Practices new to that kind of exchange need trust built in both directions first.
  • 03A useful test for any payer’s provider analytics: does a service completed last week drop off the care-gap list, or does the practice still call the patient again?

Nov 13, 2026

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

BlackRock's $2.8 billion buys majority ownership of a joint venture holding about 150 CenterWell clinics, replacing WCAS as Humana's outside investor. CenterWell keeps a minority stake and keeps running the clinics. The terms set a timeline: two years of expected growth spending, an option for Humana to buy clinics back from 2028, and a BlackRock right to start a sale of any clinics still in the venture at the end of 2033, with CenterWell getting the first offer. The deal is expected to close in the fourth quarter, subject to regulatory approvals.

  • 01BlackRock's $2.8 billion buys majority ownership of about 150 CenterWell clinics, while Humana keeps day-to-day management and an option to repurchase clinics starting in 2028.
  • 02The 2028 buyback and 2033 sale terms apply to the roughly 150 clinics in the new joint venture. CenterWell Senior Primary Care runs 250 clinics in total.
  • 03The deal’s lower-cost-of-capital claim will be tested after closing—first by how the venture deploys new capital over the next two years to support clinics, open locations and pursue acquisitions, and then by Humana’s 2028 decision on whether to start buying clinics back.

Nov 12, 2026

Healthcare AI should give doctors attention back, not shorter visits

Healthcare AI should give doctors attention back, not shorter visits

Healthcare organizations should deploy AI to give clinicians back attention and capacity for better decisions, not simply shorten visits. Landry argues AI should fit into existing workflows with insights appearing at the right time, and that organizations should set clear governance and automation boundaries before deployment and measure what changes for patients, clinicians and the organization.

  • 01AI success in healthcare should expand clinician capacity for thoughtful care, not optimize for visit speed; a three-minute appointment is not patient-centered innovation.
  • 02Design AI into workflows clinicians already use with insights appearing at the right moment, making adoption a workflow problem rather than a training problem.
  • 03Set automation boundaries before deploying AI, specifying what it may do alone, what it recommends for clinician decision-making, and what requires explicit human control and accountability.

Nov 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512